Advertisement

Topics

Private Label Nexium OTC Buoys Perrigo As Pricing Trims Rx Revenues

11:04 EST 10 Nov 2017 | SCRIP

Perrigo's third-quarter launch of private label Nexium24HR was primary contributor of $13m in new product sales in North America.

      

Related Stories

 

Original Article: Private Label Nexium OTC Buoys Perrigo As Pricing Trims Rx Revenues

NEXT ARTICLE

More From BioPortfolio on "Private Label Nexium OTC Buoys Perrigo As Pricing Trims Rx Revenues"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...